Electrodiagnostic Classification of Sensory Neuropathies: Severity Clusters and Clinical Correlates
Authors:
- Luca BoscoLBLuca Bosco
- Christian LauriniCLChristian Laurini
- Luca AngeliniLALuca Angelini
- Adele RattiARAdele Ratti
- Paride SchitoPSParide Schito
- Tommaso RussoTRTommaso Russo
- Benedetta SorrentiBSBenedetta Sorrenti
- Camilla Mirella Maria StranoCSCamilla Mirella Maria Strano
- Yuri Matteo FalzoneYFYuri Matteo Falzone
- Stefano Carlo PrevitaliSPStefano Carlo Previtali
- 1 November 2026
- journal article
- research article
- Published by Wiley in Muscle & Nerve
Abstract
Introduction/Aims: Grading sensory neuropathy severity on nerve conduction studies (NCS) is operator dependent, which limits comparisons across patients, laboratories, and studies. We aimed to develop an objective severity classification to standardize NCS reporting and support clinical decision‐making. Methods: We retrospectively analyzed NCS performed at IRCCS San Raffaele Hospital (2018–2024), extracted with a validated parser. Adult studies with sensory involvement were selected using sural sensory nerve action potential ( SNAP ) amplitude thresholds after excluding motor abnormalities. Hierarchical clustering combined normalized sural and “best” upper‐limb ( UL ) SNAP amplitudes with binary indicators for absent responses. Classes were ordered by an NCS severity index and validated against clinical scales. Results: Among 15,744 consecutive examinations, 308 met inclusion criteria. Three well‐separated NCS severity classes emerged: mild (reduced but present sural and present UL SNAPs ), moderate (absent sural, present UL SNAPs ), and severe (absent sural and UL SNAPs ). Clinical severity increased monotonically across classes. Patients in the severe class had younger age at symptom onset than those in mild‐moderate classes and were more disabled (modified Rankin scale ≥ 2: 50.0% in severe vs 30.4% in moderate vs 16.2% in mild). The severe class was enriched in immune/paraneoplastic (12.5%) and genetic (40.6%) causes. Discussion: By stratifying patients based on SNAP amplitudes, we identified a differential etiologic enrichment rather than a continuum of disease progression. Severe electrophysiology with motor sparing should prompt RFC1 testing and immune/paraneoplastic work‐up, whereas mild to moderate abnormalities should lead to assessment for diabetes and toxic or nutritional exposures.Keywords
This publication has 19 references indexed in Scilit:
- Nerve ultrasound, neuronopathy and cough predict sensory neuropathy patients with RFC1 expansionsBrain Communications, 2025
- Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort studyMuscle & Nerve, 2024
- Removing the idiopathic from the chronic sensory neuropathiesBrain, 2021
- RFC1 expansions are a common cause of idiopathic sensory neuropathyBrain, 2021
- Lumos for the long trail: Strategies for clinical diagnosis and severity staging for diabetic polyneuropathy and future directionsJournal of Diabetes Investigation, 2019
- Toronto Clinical Neuropathy Score is valid for a wide spectrum of polyneuropathiesEuropean Journal of Neurology, 2017
- Comprehensive electrophysiology in leprous neuropathy – Is there a clinico-electrophysiological dissociation?Clinical Neurophysiology, 2016
- Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trialMuscle & Nerve, 2010
- The pattern and diagnostic criteria of sensory neuronopathy: a case-control studyBrain, 2009
- Neurophysiological classification of ulnar entrapment across the elbowNeurological Sciences, 2001